Design Therapeutics, Inc. (DSGN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 227.05M | 223.78M | 209.03M | 219.79M | 233.64M | 248.04M | 257.24M | 264.84M | 273.89M | 284.58M | 294.54M | 306.05M | 318.94M | 335.12M | 348.49M | 361.72M | 373.87M | 385.44M | 395.29M | 404.88M |
| Cash & Short-Term Investments | 222.82M | 219.84M | 205.97M | 216.28M | 229.67M | 245.48M | 254.07M | 261.02M | 270.69M | 281.8M | 290.94M | 303.09M | 315.39M | 330.39M | 344.23M | 359.38M | 371.22M | 384.06M | 393.72M | 402.84M |
| Cash Only | 12.77M | 16.86M | 15.09M | 19.7M | 13.67M | 22.56M | 30.33M | 45.7M | 29.4M | 21.2M | 27.94M | 27.2M | 28.81M | 26.5M | 42.52M | 119.65M | 287.31M | 298.57M | 357.66M | 370.84M |
| Short-Term Investments | 210.05M | 202.99M | 190.88M | 196.57M | 216.01M | 222.91M | 223.75M | 215.32M | 241.29M | 260.6M | 263M | 275.89M | 286.58M | 303.89M | 301.72M | 239.72M | 83.91M | 85.5M | 36.06M | 32M |
| Accounts Receivable | 1.82M | 1.68M | 1.38M | 1.35M | 1.41M | 1.26M | 1.18M | 1.4M | 1.68M | 1.43M | 1.21M | 994K | 974K | 1.11M | 746K | 691K | 100K | 110K | 47K | 76K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 236K | 112K | 0 | 0 | 0 |
| Total Non-Current Assets | 3.39M | 2.42M | 2.74M | 3.09M | 3.83M | 4.05M | 4.39M | 4.74M | 4.91M | 5.06M | 5.33M | 5.58M | 5.8M | 6.02M | 6.08M | 6.21M | 4.93M | 5.12M | 5.06M | 271K |
| Property, Plant & Equipment | 3.39M | 2.42M | 2.74M | 3.09M | 3.4M | 3.63M | 3.96M | 4.31M | 4.48M | 4.63M | 4.89M | 5.14M | 5.35M | 5.56M | 5.62M | 5.74M | 4.93M | 5.12M | 5.06M | 271K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 427K | 427K | 427K | 429K | 427K | 430K | 437K | 444K | 452K | 459K | 466K | 474K | 0 | 0 | 0 | 0 |
| Total Assets | 230.44M | 226.2M | 211.77M | 222.89M | 237.47M | 252.09M | 261.63M | 269.58M | 278.79M | 289.64M | 299.87M | 311.63M | 324.74M | 341.14M | 354.57M | 367.93M | 378.8M | 390.56M | 400.35M | 405.15M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -2.96% | -10.27% | -19.06% | -17.32% | -14.82% | -12.96% | -12.75% | -13.49% | -14.15% | -15.09% | -15.43% | -15.3% | -14.27% | -12.65% | -11.44% | -9.19% | -8.03% | 969.55% | - | - |
| Total Current Liabilities | 10.19M | 13.05M | 11.17M | 8.75M | 8.24M | 8.46M | 7.43M | 6.39M | 7.09M | 9.62M | 12.39M | 12.13M | 9.05M | 10.78M | 10.41M | 7.39M | 5.48M | 5.28M | 5.5M | 3.4M |
| Accounts Payable | 2.28M | 2.31M | 1.91M | 1.01M | 3.18M | 2.19M | 1.47M | 1.3M | 1.37M | 1.94M | 2.21M | 1.92M | 2.74M | 3.02M | 2.62M | 2.07M | 1.9M | 1.62M | 2.22M | 1.58M |
| Days Payables Outstanding | - | -13.18 | 9.23 | 1.26K | - | - | - | 804.24 | 1.05K | - | 1.39K | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 866K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.33M | 10.74M | 4.93M | 2.5M | 1.9M | 3.58M | 2.99M | 2.39M | 2.07M | 4.03M | 4.07M | 2.41M | 1.79M | 3.54M | 2.7M | 1.91M | 1.44M | 2.15M | 1.41M | 941K |
| Current Ratio | 22.28x | 17.14x | 18.71x | 25.13x | 28.37x | 29.31x | 34.61x | 41.42x | 38.61x | 29.58x | 23.77x | 25.22x | 35.25x | 31.10x | 33.47x | 48.96x | 68.22x | 72.96x | 71.81x | 118.91x |
| Quick Ratio | 22.28x | 17.14x | 18.71x | 25.13x | 28.37x | 29.31x | 34.61x | 41.42x | 38.61x | 29.58x | 23.77x | 25.22x | 35.25x | 31.10x | 33.47x | 48.96x | 68.22x | 72.96x | 71.81x | 118.91x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.2M | 645K | 877K | 1.1M | 1.32M | 1.53M | 1.74M | 1.95M | 2.14M | 2.33M | 2.52M | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 3.01M | 3.14M | 3.28M | 140K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 2.2M | 645K | 877K | 1.1M | 1.32M | 1.53M | 1.74M | 1.95M | 2.14M | 2.33M | 2.52M | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 3.01M | 3.14M | 3.27M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11K | 140K |
| Total Liabilities | 12.39M | 13.7M | 12.05M | 9.85M | 9.56M | 10M | 9.18M | 8.34M | 9.24M | 11.96M | 14.91M | 14.84M | 11.93M | 13.83M | 13.63M | 10.77M | 8.49M | 8.43M | 8.79M | 3.54M |
| Total Debt | 2.73M | 645K | 1.74M | 1.95M | 2.14M | 2.33M | 2.52M | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 3.54M | 3.69M | 3.84M | 3.98M | 3.52M | 3.63M | 3.75M | 0 |
| Net Debt | -10.04M | -16.21M | -13.35M | -17.76M | -11.53M | -20.23M | -27.81M | -43M | -26.52M | -18.15M | -24.72M | -23.82M | -25.27M | -22.81M | -38.68M | -115.67M | -283.8M | -294.94M | -353.91M | -370.84M |
| Debt / Equity | 0.01x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 218.05M | 212.5M | 199.72M | 213.04M | 227.92M | 242.1M | 252.45M | 261.24M | 269.56M | 277.69M | 284.96M | 296.8M | 312.82M | 327.31M | 340.94M | 357.16M | 370.31M | 382.13M | 391.56M | 401.6M |
| Equity Growth % | -4.33% | -12.22% | -20.89% | -18.45% | -15.45% | -12.82% | -11.41% | -11.98% | -13.83% | -15.16% | -16.42% | -16.9% | -15.53% | -14.35% | -12.93% | -11.07% | -9.24% | 3477.2% | - | - |
| Book Value per Share | 3.55 | 3.71 | 3.51 | 3.75 | 4.02 | 4.27 | 4.46 | 4.62 | 4.77 | 4.95 | 5.09 | 5.30 | 5.60 | 5.86 | 6.11 | 6.42 | 6.67 | 6.90 | 7.10 | 7.29 |
| Total Shareholders' Equity | 218.05M | 212.5M | 199.72M | 213.04M | 227.92M | 242.1M | 252.45M | 261.24M | 269.56M | 277.69M | 284.96M | 296.8M | 312.82M | 327.31M | 340.94M | 357.16M | 370.31M | 382.13M | 391.56M | 401.6M |
| Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
| Retained Earnings | -314.64M | -297.01M | -281.01M | -264.01M | -244.93M | -227.21M | -213.56M | -200.52M | -188.73M | -177.63M | -165.78M | -150M | -130.06M | -110.76M | -93.42M | -75.72M | -60.72M | -47.46M | -36.39M | -25.07M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -268K | 403K | 358K | 305K | 450K | 475K | 914K | -217K | -167K | 62K | -1.28M | -2M | -1.98M | -3.36M | -3.86M | -2.31M | -1.32M | -244K | -4K | -12K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |